title: Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease.
authors.affiliation: Department of Paediatrics, University of Oxford, Level 2, Children's Hospital, Oxford OX3 9DU, UK. andrew.pollard@paediatrics.ox.ac.uk
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Pollard
authors.forename: Christopher
authors.initials: C
authors.lastname: Green
authors.forename: Manish
authors.initials: M
authors.lastname: Sadarangani
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Snape
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007117:Immunization, Secondary; D007223:Infant; D032541:Mass Vaccination / Q000592:standards*; D008589:Meningococcal Infections / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control; D022401:Meningococcal Vaccines / Q000008:administration & dosage* / Q000276:immunology; D038542:Neisseria meningitidis, Serogroup C / Q000276:immunology*; D006113:United Kingdom / Q000453:epidemiology; D018074:Vaccines, Conjugate / Q000008:administration & dosage / Q000276:immunology; D055815:Young Adult
chemical_list: D022401:Meningococcal Vaccines; D018074:Vaccines, Conjugate